2,103,702 Shares OptimizeRx Corporation Common Stock, par value $0.001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • December 18th, 2018 • OptimizeRx Corp • Services-business services, nec • New York
The selling shareholder named in Schedule I hereto (the “Selling Shareholder”) proposes to sell to the several Underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of 2,103,702 shares (the “Firm Shares”) of Common Stock, par value $0.001 per share (the “Common Stock”), of OptimizeRx Corporation, a Nevada corporation (the “Company”). The Company has also granted to the several Underwriters an option to purchase up to 315,555 additional shares of Common Stock on the terms and for the purposes set forth in Section 4 hereof (collectively, the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
